Benzinga's Volume Movers

Exact Sciences EXAS shares moved up 6.21% to $18.15. The volume of Exact Sciences shares traded was 2588% higher than normal. Exact Sciences announced the FDA approval of Cologuard. Intercept Pharmaceuticals ICPT surged 27.49% to $302.38. The volume of Intercept Pharmaceuticals shares traded 1902% higher than normal. Intercept Pharma released Q2 earnings report and business update. Leerink Swann upgraded Intercept from Market Perform to Outperform and raised the price target from $270.00 to $445.00. Kate Spade & Company KATE shares climbed 7.29% to $41.70. The volume of Kate Spade shares traded was 452% higher than normal. Kate Spade reported upbeat second-quarter results. Mindray Medical International MR shares rose 5.81% to $31.71. The volume of Mindray Medical shares traded was 384% higher than normal. Mindray Medical reported Q2 adjusted earnings of $0.54 per share and lowered its FY capex outlook.